Description

• IV preparation. Clear colourless solution 1mmol/ml (0.75 gm in 10ml).
• Oral preparation - clear and colourless 2 mmol/ml (osmolality 4000mOsm/kg/)

• For an infusion to correct symptomatic hypokalaemia, charted on stat page of prescription chart stating mmol/dose and fluid to be diluted in type and volume, time to be infused.
• For oral supplementation, charted on prescription chart stating ml/dose, frequency, and mmol/kg/day.

• Charted on fluid chart only stating 1 molar potassium chloride and volume to be added.

• Charted on prescription chart stating ml/dose.

Administration

1. For central line administration, dilute prior to use to 1 mmol in 12.5ml (80mmol/L) with NS, D5W or D10W. Stronger solutions are unacceptable. Mix well.
2. For peripheral line administration, dilute prior to use to 1mmol in 25ml (40mmol/L) with NS, D5W or D10W. Mix well.
3. Administer by slow IV infusion Y injection port of minibore tubing.  Keep IV fluids running to ensure further dilution of potassium. Compatible for co-infusion with IVN at Y injection site.
4. Do NOT mix with other drugs, blood or blood products.

1. Shake well before use.
2. Administer with feeds to decrease likelihood of gastro-intestinal reactions.

Observation and Documentation

1. Monitor for adverse reactions.
2. Observe site closely for extravasation.
3. Continuous cardiac monitoring during administration of slow IV infusion by syringe pump.
4. Monitor K+ levels closely following slow infusions.
5. Assess for gastrointestinal intolerance of oral potassium.

Storage

• At room temperature <30°C. Discard ampoule after use.
• Oral: Store in refrigerator. Discard after 1 week.

Selected References